Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...

Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...

By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...

The University of Liverpool's Centre of Excellence for Long-acting Therapeutics - Global Health (CELT Global Health) is part of a new public-private ...

CELT Global Health part of new initiative to accelerate innovation against drug-resistant bacterial infections ...

Amid short days and long nights, the simple act of nurturing plants can lift mood, sharpen focus, and cultivate quiet resilience ...

Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...

Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, insurance portfolio management, finance and accounting, personal investment and financial ...

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Tuberculosis (TB) is an infectious disease caused by strains of bacteria known as mycobacteria. The disease most commonly affects the lungs and can be fatal if not treated. However, most infected ...